Evidence map›Paper›PMID 29038474›Full record

ArticleNature communications2017

A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development.

Ai-Ping Mao, Isabel E Ishizuka, Darshan N Kasal, Malay Mandal, Albert Bendelac

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. A population-scale atlas of blood and tissue in lupus nephritis.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Genome-Wide Association Studies in Japanese Quails of the FInternational journal of molecular sciences · 2025
    Article
  8. Review
  9. Primordial Cells Bridging the Gap Between Innate and Adaptive Immunity.Advances in experimental medicine and biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. CD169iScience · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Purification of Bone Marrow Precursors to T Cells and ILCs.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  20. FXR mediates ILC-intrinsic responses to intestinal inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ai-Ping MaoCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA.
Isabel E IshizukaCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA.
Darshan N KasalCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA.
Malay MandalCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA.ORCID http://orcid.org/0000-0002-0451-3896
Albert BendelacCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA. abendela@bsd.uchicago.edu.
University of Chicago · US

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI ABADIE, VALERIE · 1990 to 2025
$29.8M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
Transcriptional Regulation of Innate-Like T CellsR01AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI ESTERHAZY, DARIA · 1996 to 2025
$7.6M
Transcriptional Regulation of Innate-Like T CellsR37AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2017 to 2023
$3.4M
A common hematopoietic precursor to innate lymphoid cellsR01AI108643 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2014 to 2017
$1.5M
NIAID NIH HHS R01 AI038339NIAID NIH HHS R01 AI108643NIAID NIH HHS R37 AI038339NIAID NIH HHS T32 AI007090NIDDK NIH HHS P30 DK042086
6 · The paper itself

Abstract

Zbtb16-encoded PLZF is a signature transcription factor (TF) that directs the acquisition of T-helper effector programs during the development of multiple innate lymphocyte lineages, including natural killer T cell, innate lymphoid cell, mucosal-associated invariant T cell and γδ lineages. PLZF is also essential in osteoblast and spermatogonial development. How Zbtb16 itself is regulated in different lineages is incompletely understood. Here, by systematic CRISPR/Cas9-assisted deletions of chromatin accessible regions within the Zbtb16 locus in mouse, we identify a critical enhancer controlling PLZF expression exclusively in innate lymphoid lineages. Multiple sites within this enhancer express canonical motifs for the TF Runx1, which is essential for the development of these lineages. Notably, some regulatory sites control the kinetic rather than the overall level of PLZF expression. Thus, our comprehensive, unbiased analysis of regulatory elements in vivo reveals critical mechanisms of Zbtb16 regulation shared between innate and innate-like lymphoid lineages. Zbtb16-encoded transcription factor PLZF directs the differentiation of multiple innate and innate-like cell lineages, but how Zbtb16 itself is regulated remains unclear. Here the authors show, using CRISPR gene editing, ATAC-seq and ChIP-seq, that specific Runx1-bound enhancer elements critically modulate lineage-dependent expressions of PLZF.

Indexed as

AnimalsCell DifferentiationCell LineageCore Binding Factor Alpha 2 SubunitCRISPR-Cas SystemsEnhancer Elements, GeneticEpigenesis, GeneticImmunity, InnateIntraepithelial LymphocytesLymphocytesLymphopoiesisMiceMice, KnockoutNatural Killer T-CellsPromyelocytic Leukemia Zinc Finger ProteinRegulatory Sequences, Nucleic AcidCore Binding Factor Alpha 2 SubunitPromyelocytic Leukemia Zinc Finger ProteinRunx1 protein, mouseZbtb16 protein, mouse

Identifiers

PMID29038474
PMCPMC5643357
OpenAlexW2761994748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.